Related Experiment Videos
[Cost analysis in patients admitted with COPD in 2002].
Irina Strâmbu1, Simona Bucşa, Daniela Nicolescu
1Institutul de Pneumologie "Marius Nasta", Bucureşti.
Pneumologia (Bucharest, Romania)
|August 19, 2005
Summary
Hospital admissions for Chronic Obstructive Pulmonary Disease (COPD) are lengthy and costly, particularly for severe stages. While overall costs are lower than in Europe, hospital stay constitutes the largest expense.
Area of Science:
- Pulmonology
- Health Economics
Context:
- Chronic Obstructive Pulmonary Disease (COPD) poses a significant financial burden on healthcare systems.
- Understanding the cost of hospital admissions is crucial for resource allocation and management.
Purpose:
- To assess the costs associated with hospital admissions for COPD patients.
- To determine the financial burden of COPD on a high-level respiratory unit.
Summary:
- Retrospective analysis of 181 COPD patient charts admitted between January and September 2002.
- Average admission duration was 17.18 days, with a mean cost of 727 Euro.
- Costs were divided into lab tests (170 Euro), medication (126 Euro), and hospital stay (432 Euro).
- Patients were predominantly in severe COPD stages (III and IV).
- Costs increased significantly for Stage IV COPD patients.
Impact:
- Highlights that over half of the costs are attributed to hospital stay, suggesting areas for potential cost-saving measures.
- Provides data on COPD patient demographics and disease severity at admission.
- Offers insights into the economic impact of COPD in a specific healthcare setting, useful for comparative studies.